Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies

Standard

Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. / Lehmberg, Kai; Nichols, Kim E; Henter, Jan-Inge; Girschikofsky, Michael; Greenwood, Tatiana; Jordan, Michael; Kumar, Ashish; Minkov, Milen; La Rosée, Paul; Weitzman, Sheila; Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte Society.

In: HAEMATOLOGICA, Vol. 100, No. 8, 08.2015, p. 997-1004.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Lehmberg, K, Nichols, KE, Henter, J-I, Girschikofsky, M, Greenwood, T, Jordan, M, Kumar, A, Minkov, M, La Rosée, P, Weitzman, S & Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte Society 2015, 'Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies', HAEMATOLOGICA, vol. 100, no. 8, pp. 997-1004. https://doi.org/10.3324/haematol.2015.123562

APA

Lehmberg, K., Nichols, K. E., Henter, J-I., Girschikofsky, M., Greenwood, T., Jordan, M., Kumar, A., Minkov, M., La Rosée, P., Weitzman, S., & Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte Society (2015). Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. HAEMATOLOGICA, 100(8), 997-1004. https://doi.org/10.3324/haematol.2015.123562

Vancouver

Bibtex

@article{49c1381a2e3b4a48bed7008b6dd7be47,
title = "Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies",
abstract = "The hyperinflammatory syndrome hemophagocytic lymphohistiocytosis can occur in the context of malignancies. Malignancy-triggered hemophagocytic lymphohistiocytosis should be regarded separately from hemophagocytic lymphohistiocytosis during chemotherapeutic treatment, which is frequently associated with an infectious trigger. The substantial overlap between the features of hemophagocytic lymphohistiocytosis with features of neoplasms makes its identification difficult when it occurs in malignant conditions. To facilitate recognition and diagnostic workup, and provide guidance regarding the treatment of malignancy-associated hemophagocytic lymphohistiocytosis, consensus recommendations were developed by the Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte Society, an interdisciplinary group consisting of pediatric and adult hemato-oncologists and immunologists.",
keywords = "Disease Management, Humans, Lymphohistiocytosis, Hemophagocytic, Neoplasms",
author = "Kai Lehmberg and Nichols, {Kim E} and Jan-Inge Henter and Michael Girschikofsky and Tatiana Greenwood and Michael Jordan and Ashish Kumar and Milen Minkov and {La Ros{\'e}e}, Paul and Sheila Weitzman and {Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte Society}",
note = "Copyright{\textcopyright} Ferrata Storti Foundation.",
year = "2015",
month = aug,
doi = "10.3324/haematol.2015.123562",
language = "English",
volume = "100",
pages = "997--1004",
journal = "HAEMATOLOGICA",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "8",

}

RIS

TY - JOUR

T1 - Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies

AU - Lehmberg, Kai

AU - Nichols, Kim E

AU - Henter, Jan-Inge

AU - Girschikofsky, Michael

AU - Greenwood, Tatiana

AU - Jordan, Michael

AU - Kumar, Ashish

AU - Minkov, Milen

AU - La Rosée, Paul

AU - Weitzman, Sheila

AU - Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte Society

N1 - Copyright© Ferrata Storti Foundation.

PY - 2015/8

Y1 - 2015/8

N2 - The hyperinflammatory syndrome hemophagocytic lymphohistiocytosis can occur in the context of malignancies. Malignancy-triggered hemophagocytic lymphohistiocytosis should be regarded separately from hemophagocytic lymphohistiocytosis during chemotherapeutic treatment, which is frequently associated with an infectious trigger. The substantial overlap between the features of hemophagocytic lymphohistiocytosis with features of neoplasms makes its identification difficult when it occurs in malignant conditions. To facilitate recognition and diagnostic workup, and provide guidance regarding the treatment of malignancy-associated hemophagocytic lymphohistiocytosis, consensus recommendations were developed by the Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte Society, an interdisciplinary group consisting of pediatric and adult hemato-oncologists and immunologists.

AB - The hyperinflammatory syndrome hemophagocytic lymphohistiocytosis can occur in the context of malignancies. Malignancy-triggered hemophagocytic lymphohistiocytosis should be regarded separately from hemophagocytic lymphohistiocytosis during chemotherapeutic treatment, which is frequently associated with an infectious trigger. The substantial overlap between the features of hemophagocytic lymphohistiocytosis with features of neoplasms makes its identification difficult when it occurs in malignant conditions. To facilitate recognition and diagnostic workup, and provide guidance regarding the treatment of malignancy-associated hemophagocytic lymphohistiocytosis, consensus recommendations were developed by the Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte Society, an interdisciplinary group consisting of pediatric and adult hemato-oncologists and immunologists.

KW - Disease Management

KW - Humans

KW - Lymphohistiocytosis, Hemophagocytic

KW - Neoplasms

U2 - 10.3324/haematol.2015.123562

DO - 10.3324/haematol.2015.123562

M3 - SCORING: Journal article

C2 - 26314082

VL - 100

SP - 997

EP - 1004

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

SN - 0390-6078

IS - 8

ER -